About Dr. Zheng Zhizhong
Dr. Zheng Zhizhong (郑志忠) is one of China's most eminent dermatologists and the Director of the Department of Dermatology at Zhongshan Hospital, affiliated with Fudan University. He holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on psoriasis, autoimmune skin diseases, and inflammatory dermatology.
Over a career spanning more than four decades, Dr. Zheng has established himself as one of China's most experienced and respected dermatologists, with a particular focus on psoriasis — a condition he has studied and treated for his entire career. His contributions to China's understanding of psoriasis pathogenesis, epidemiology, and treatment have been foundational, and his clinical experience with psoriasis patients is among the deepest in the country.
International patients with psoriasis, autoimmune skin diseases, or complex inflammatory dermatological conditions consistently identify Dr. Zheng as one of Shanghai's top dermatologists for both primary treatment and expert second opinions.
Professional Positions and Affiliations
- Director, Department of Dermatology, Zhongshan Hospital, Fudan University
- Past Chairman, Psoriasis Committee, Chinese Society of Dermatology
- Honorary President, Chinese Society of Dermatology
- Editorial Board Member: Journal of the European Academy of Dermatology and Venereology (JEADV), Chinese Journal of Dermatology
- Member, International Psoriasis Council (IPC)
- Member, European Academy of Dermatology and Venereology (EADV)
Specialties and Clinical Expertise
- Psoriasis — plaque, guttate, pustular, erythrodermic, and nail psoriasis; biologic therapy (IL-17 inhibitors: secukinumab, ixekizumab; IL-23 inhibitors: guselkumab, risankizumab, tildrakizumab; TNF inhibitors; IL-12/23 inhibitor: ustekinumab); small molecule therapy (apremilast, deucravacitinib); phototherapy (NB-UVB, PUVA); traditional Chinese medicine integration for psoriasis management
- Psoriatic Arthritis — coordinated care with rheumatology; biologic and small molecule therapy
- Autoimmune Bullous Diseases — pemphigus vulgaris, bullous pemphigoid, and mucous membrane pemphigoid; rituximab and immunosuppressive protocols
- Atopic Dermatitis — dupilumab, tralokinumab, and JAK inhibitor therapy; proactive maintenance strategies
- Urticaria and Allergic Skin Disease — chronic spontaneous urticaria; omalizumab therapy
- Skin Oncology — melanoma, basal cell carcinoma, and squamous cell carcinoma; coordination with surgical oncology
- Vitiligo — JAK inhibitor therapy (ruxolitinib cream), NB-UVB phototherapy
- Cosmetic Dermatology — laser treatments, chemical peels, and injectable therapies for skin rejuvenation
Academic and Research Contributions
Dr. Zheng Zhizhong has published over 200 peer-reviewed papers in leading international dermatology journals over his four-decade career, with a particular focus on psoriasis pathogenesis, epidemiology in Chinese patients, and the clinical outcomes of biologic therapy. His early research on the genetic basis of psoriasis in Chinese patients — identifying HLA associations distinct from those in Western populations — was foundational for understanding ethnic differences in psoriasis biology.
He served as Chairman of the Psoriasis Committee of the Chinese Society of Dermatology for multiple terms and is now Honorary President of the society, reflecting his lifetime contribution to Chinese dermatology. He is a member of the International Psoriasis Council (IPC) and a regular invited speaker at EADV, the World Congress of Dermatology (WCD), and the International Psoriasis Symposium.
Why International Patients Choose Dr. Zheng Zhizhong
- Four decades of psoriasis expertise — among the deepest clinical experience in China
- Honorary President of the Chinese Society of Dermatology — lifetime achievement recognition
- International Psoriasis Council member — globally connected in psoriasis research and treatment
- Full biologic therapy access — all approved IL-17, IL-23, and IL-4/13 inhibitors
- TCM integration for psoriasis — unique integrative approach combining Western biologics with traditional medicine
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Zhongshan Hospital, 180 Fenglin Road, Xuhui District, Shanghai
- Appointment Lead Time: 2″3 weeks; urgent cases expedited through CMCS
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas treatment history, biopsy results, and prior biologic therapy records reviewed remotely through CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking dermatology care with Dr. Zheng Zhizhong at Zhongshan Hospital. Our services include priority appointment booking, medical record and biopsy report translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-treatment follow-up with your home country dermatologist.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 comentarios